"Sales of Biogen’s two other major drugs, Tysabri and Avonex, which are both injected MS treatments, also rose during the second quarter. Sales of Tysabri climbed 38% to $387 million while sales of Avonex rose 3.8% to $774 million. Tysabri is a humanized monoclonal antibody, and Avonex is a traditional interferon-based treatment"
38% increase. Let me repeat that 38% increase. Your hate makes you stupid.
In May you claimed that it would be $130 by August. You are currently off by $176/share.
Currently up 41% YTD.
You say my hate makes me stupid. I have a right to my opinion without being called stupid. Calling names is very childish and immature. You need to grow up. People like you that work for Biogen is what gives companies bad names. Take your comments back to the play ground chump.